Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Early Phase 1
3(75.0%)
N/A
1(25.0%)
4Total
Early Phase 1(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06624904Early Phase 1Recruiting

Losartan and Social Processing

Role: collaborator

NCT06636812Early Phase 1Recruiting

Losartan and Emotional Processing in Young People

Role: collaborator

NCT06628154Early Phase 1Recruiting

Losartan and Emotional Learning

Role: collaborator

NCT03554694Not ApplicableUnknown

Gut-brain Axis, Brain Function, and Behaviour.

Role: collaborator

All 4 trials loaded